{
    "references": [
        {
            "bibentry": "Alzheimer’s Disease International Alzheimer’s disease International. World Alzheimer Report 2018. The state of the art of dementia research: new frontiers. London: Alzheimer’s Disease International; 2018.",
            "process_entry": "True",
            "xmlid": "CIT0001"
        },
        {
            "bibentry": "Tarawneh, R, Holtzman, DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med 2012; 2: a006148. PMID: 22553492",
            "process_entry": "True",
            "doi": "10.1101/cshperspect.a006148",
            "pmid": "22553492",
            "pmcid": "PMC3331682",
            "xmlid": "CIT0002"
        },
        {
            "bibentry": "Whitehouse, PJ, Price, DL, Struble, RG, et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237–9. PMID: 7058341",
            "process_entry": "True",
            "doi": "10.1126/science.7058341",
            "pmid": "7058341",
            "xmlid": "CIT0003"
        },
        {
            "bibentry": "Moya-Alvarado, G, Gershoni-Emek, N, Perlson, E, Bronfman, FC. Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain? Mol Cell Proteomics 2016; 15: 409–25. PMID: 26657538",
            "process_entry": "True",
            "doi": "10.1074/mcp.R115.053330",
            "pmid": "26657538",
            "pmcid": "PMC4739664",
            "xmlid": "CIT0004"
        },
        {
            "bibentry": "Prasansuklab, A, Tencomnao, T. Amyloidosis in Alzheimer's disease: the toxicity of amyloid beta (A beta), mechanisms of its accumulation and implications of medicinal plants for therapy. Evid Based Complement Alternat Med 2013; 2013: 1.",
            "process_entry": "True",
            "xmlid": "CIT0005"
        },
        {
            "bibentry": "Tonnies, E, Trushina, E. Oxidative stress, synaptic dysfunction, and Alzheimer's disease. J Alzheimers Dis 2017; 57: 1105–21. PMID: 28059794",
            "process_entry": "True",
            "doi": "10.3233/JAD-161088",
            "pmid": "28059794",
            "pmcid": "PMC5409043",
            "xmlid": "CIT0006"
        },
        {
            "bibentry": "Ferreira-Vieira, TH, Guimaraes, IM, Silva, FR, Ribeiro, FM. Alzheimer's disease: targeting the cholinergic system. Curr Neuropharmacol 2016; 14: 101–15. PMID: 26813123",
            "process_entry": "True",
            "doi": "10.2174/1570159X13666150716165726",
            "pmid": "26813123",
            "pmcid": "PMC4787279",
            "xmlid": "CIT0007"
        },
        {
            "bibentry": "Ozgun, DO, Yamali, C, Gul, HI, et al. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J Enzyme Inhib Med Chem 2016; 31: 1498–501. PMID: 26928426",
            "process_entry": "True",
            "doi": "10.3109/14756366.2016.1149479",
            "pmid": "26928426",
            "xmlid": "CIT0008"
        },
        {
            "bibentry": "Gülçin, İ, Scozzafava, A, Supuran, CT, et al. The effect of caffeic acid phenethyl ester (CAPE) on metabolic enzymes including acetylcholinesterase, butyrylcholinesterase, glutathione S-transferase, lactoperoxidase, and carbonic anhydrase isoenzymes I, II, IX, and XII. J Enzyme Inhib Med Chem 2016; 31: 1095–101. PMID: 26453427",
            "process_entry": "True",
            "doi": "10.3109/14756366.2015.1094470",
            "pmid": "26453427",
            "xmlid": "CIT0009"
        },
        {
            "bibentry": "Woolf, NJ, Butcher, LL. Cholinergic systems mediate action from movement to higher consciousness. Behav Brain Res 2011; 221: 488–98. PMID: 20060422",
            "process_entry": "True",
            "doi": "10.1016/j.bbr.2009.12.046",
            "pmid": "20060422",
            "xmlid": "CIT0010"
        },
        {
            "bibentry": "Coyle, JT, Price, DL, DeLong, MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983; 219: 1184–90. PMID: 6338589",
            "process_entry": "True",
            "doi": "10.1126/science.6338589",
            "pmid": "6338589",
            "xmlid": "CIT0011"
        },
        {
            "bibentry": "Perry, E, Walker, M, Grace, J, Perry, R. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci 1999; 22: 273–80. PMID: 10354606",
            "process_entry": "True",
            "doi": "10.1016/s0166-2236(98)01361-7",
            "pmid": "10354606",
            "xmlid": "CIT0012"
        },
        {
            "bibentry": "Bazelyansky, M, Robey, E, Kirsch, JF. Fractional diffusion-limited component of reactions catalyzed by acetylcholinesterase. Biochemistry 1986; 25: 125–30. PMID: 3954986",
            "process_entry": "True",
            "doi": "10.1021/bi00349a019",
            "pmid": "3954986",
            "xmlid": "CIT0013"
        },
        {
            "bibentry": "Massoulie, J, Pezzementi, L, Bon, S, et al. Molecular and cellular biology of cholinesterases. Prog Neurobiol 1993; 41: 31–91. PMID: 8321908",
            "process_entry": "True",
            "doi": "10.1016/0301-0082(93)90040-y",
            "pmid": "8321908",
            "xmlid": "CIT0014"
        },
        {
            "bibentry": "Darreh-Shori, T, Forsberg, A, Modiri, N, et al. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiol Aging 2011; 32: 2320.e15–32.",
            "process_entry": "True",
            "xmlid": "CIT0015"
        },
        {
            "bibentry": "Mushtaq, G, Greig, NH, Khan, JA, Kamal, MA. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets 2014; 13: 1432–9. PMID: 25345511",
            "process_entry": "True",
            "doi": "10.2174/1871527313666141023141545",
            "pmid": "25345511",
            "pmcid": "PMC5878042",
            "xmlid": "CIT0016"
        },
        {
            "bibentry": "Lane, RG, Potkin, S, Enz, A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol 2006; 9: 101–24. PMID: 16083515",
            "process_entry": "True",
            "doi": "10.1017/s1461145705005833",
            "pmid": "16083515",
            "xmlid": "CIT0017"
        },
        {
            "bibentry": "Selkoe, DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: A23–31. PMID: 10392577",
            "process_entry": "True",
            "doi": "10.1038/399a023",
            "pmid": "10392577",
            "xmlid": "CIT0018"
        },
        {
            "bibentry": "Li, Q, Yang, H, Chen, Y, Sun, H. Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease. Eur J Med Chem 2017; 132: 294–309. PMID: 28371641",
            "process_entry": "True",
            "doi": "10.1016/j.ejmech.2017.03.062",
            "pmid": "28371641",
            "xmlid": "CIT0019"
        },
        {
            "bibentry": "Sujayev, A, Garibov, E, Taslimi, P, et al. Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase. J Enzyme Inhib Med Chem 2016; 31: 1531–9. PMID: 27050248",
            "process_entry": "True",
            "doi": "10.3109/14756366.2016.1156104",
            "pmid": "27050248",
            "xmlid": "CIT0020"
        },
        {
            "bibentry": "Turan, B, Şendil, K, Şengül, E, et al. The synthesis of some β-lactams and investigation of their metal-chelating activity, carbonic anhydrase and acetylcholinesterase inhibition. J Enzyme Inhib Med Chem 2016; 31: 79–88.",
            "process_entry": "True",
            "xmlid": "CIT0021"
        },
        {
            "bibentry": "Stahl, SM. The new cholinesterase inhibitors for Alzheimer's disease, part 2: illustrating their mechanisms of action. J Clin Psychiatry 2000; 61: 813–4. PMID: 11105732",
            "process_entry": "True",
            "doi": "10.4088/jcp.v61n1101",
            "pmid": "11105732",
            "xmlid": "CIT0022"
        },
        {
            "bibentry": "Thompson, PA, Wright, DE, Counsell, CE, Zajicek, J. Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review. Int Psychogeriatr 2012; 24: 689–97. PMID: 21910950",
            "process_entry": "True",
            "doi": "10.1017/s1041610211001116",
            "pmid": "21910950",
            "xmlid": "CIT0023"
        },
        {
            "bibentry": "Macdonald, IR, Rockwood, K, Martin, E, Darvesh, S. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer? J Alzheimers Dis 2014; 42: 379–84. PMID: 24898642",
            "process_entry": "True",
            "doi": "10.3233/jad-140219",
            "pmid": "24898642",
            "xmlid": "CIT0024"
        },
        {
            "bibentry": "Prvulovic, D, Schneider, B. Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease. Expert Opin Drug Metab Toxicol 2014; 10: 1039–50. PMID: 24785550",
            "process_entry": "True",
            "doi": "10.1517/17425255.2014.915028",
            "pmid": "24785550",
            "xmlid": "CIT0025"
        },
        {
            "bibentry": "Birks, JS, Grimley Evans, J. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev 2015; 4: Cd001191.",
            "process_entry": "True",
            "xmlid": "CIT0026"
        },
        {
            "bibentry": "Olin, J, Schneider, L. Galantamine for Alzheimer's disease. Cochrane Database Syst Rev 2002; 4: Cd001747.",
            "process_entry": "True",
            "xmlid": "CIT0027"
        },
        {
            "bibentry": "Birks, J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev 2006; 1: Cd005593.",
            "process_entry": "True",
            "xmlid": "CIT0028"
        },
        {
            "bibentry": "Brus, B, Kosak, U, Turk, S, et al. Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. J Med Chem 2014; 57: 8167–79. PMID: 25226236",
            "process_entry": "True",
            "doi": "10.1021/jm501195e",
            "pmid": "25226236",
            "xmlid": "CIT0029"
        },
        {
            "bibentry": "Molecular Operating Environment (MOE). Chemical Computing Group. Montreal, Canada 2016. Available from: http://www.chemcomp.com,",
            "process_entry": "True",
            "url": "http://www.chemcomp.com,",
            "xmlid": "CIT0030"
        },
        {
            "bibentry": "Halgren, TA. Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules. J Comput Chem 1996; 17: 616–41.",
            "process_entry": "True",
            "xmlid": "CIT0031"
        },
        {
            "bibentry": "Sastry, GM, Adzhigirey, M, Day, T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 2013; 27: 221–34. PMID: 23579614",
            "process_entry": "True",
            "doi": "10.1007/s10822-013-9644-8",
            "pmid": "23579614",
            "xmlid": "CIT0032"
        },
        {
            "bibentry": "Friesner, RA, Banks, JL, Murphy, RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004; 47: 1739–49. PMID: 15027865",
            "process_entry": "True",
            "doi": "10.1021/jm0306430",
            "pmid": "15027865",
            "xmlid": "CIT0033"
        },
        {
            "bibentry": "Veber, DF, Johnson, SR, Cheng, HY, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 2002; 45: 2615–23. PMID: 12036371",
            "process_entry": "True",
            "doi": "10.1021/jm020017n",
            "pmid": "12036371",
            "xmlid": "CIT0034"
        },
        {
            "bibentry": "Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001; 46: 3–26. PMID: 11259830",
            "process_entry": "True",
            "doi": "10.1016/s0169-409x(00)00129-0",
            "pmid": "11259830",
            "xmlid": "CIT0035"
        },
        {
            "bibentry": "Takaoka, Y, Endo, Y, Yamanobe, S, et al. Development of a method for evaluating drug-likeness and ease of synthesis using a data set in which compounds are assigned scores based on chemists' intuition. J Chem Inform Comput Sci 2003; 43: 1269–75.",
            "process_entry": "True",
            "xmlid": "CIT0036"
        },
        {
            "bibentry": "Ellman, GL, Courtney, KD, Andres, V, Jr, Feather-Stone, RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95. PMID: 13726518",
            "process_entry": "True",
            "doi": "10.1016/0006-2952(61)90145-9",
            "pmid": "13726518",
            "xmlid": "CIT0037"
        },
        {
            "bibentry": "Atatreh, N, Ghattas, MA, Bardaweel, SK, et al. Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening. Drug Des Devel Ther 2018; 12: 3741–52.",
            "process_entry": "True",
            "xmlid": "CIT0038"
        },
        {
            "bibentry": "Bajda, M, Więckowska, A, Hebda, M, et al. Structure-based search for new inhibitors of cholinesterases. Int J Mol Sci 2013; 14: 5608–32. PMID: 23478436",
            "process_entry": "True",
            "doi": "10.3390/ijms14035608",
            "pmid": "23478436",
            "pmcid": "PMC3634507",
            "xmlid": "CIT0039"
        },
        {
            "bibentry": "Dighe, SN, Deora, GS, De la Mora, E, et al. Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening. J Med Chem 2016; 59: 7683–9. PMID: 27405689",
            "process_entry": "True",
            "doi": "10.1021/acs.jmedchem.6b00356",
            "pmid": "27405689",
            "xmlid": "CIT0040"
        },
        {
            "bibentry": "Jin, H. Acetylcholinesterase and butyrylcholinesterase inhibitory properties of functionalized tetrahydroacridines and related analogs. 2014; 4: 688–96.",
            "process_entry": "True",
            "xmlid": "CIT0041"
        }
    ],
    "localid": "MED-31347933",
    "doi": "10.1080/14756366.2019.1644329",
    "pmid": "10.1080/14756366.2019.1644329",
    "pmcid": "31347933",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/31347933/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "CIT0001",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),144,191)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "CIT0002",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,123)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "CIT0003",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),1,123)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),125,96)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "CIT0005",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),222,210)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "CIT0006",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),222,210)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0007",
                "rp_string": "7–9",
                "pl_string": "7–9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),433,284)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 7,
                "xref_id": "CIT0008",
                "pl_string": "7–9",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),433,284)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 8,
                "xref_id": "CIT0009",
                "pl_string": "7–9",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),433,284)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "CIT0007",
                "rp_string": "7–9",
                "pl_string": "7–9",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "pl_xpath": "/article/body/sec[1]/p[2]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),433,284)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "CIT0010",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1,155)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "CIT0011",
                "rp_string": "11",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),157,190)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 12,
                "xref_id": "CIT0012",
                "rp_string": "12",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),348,176)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Cholinesterase is the enzyme which catalyses the hydrolysis of ACh and thus inhibition of cholinesterase can be an effective way for the treatment of AD10. It is well-known that two different cholinesterase (ChE) enzymes, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE), are responsible for the hydrolysis of ACh within the brain11. However, AChE has stronger acetylcholine hydrolytic activity than BChE does under the same condition12, as former enzyme can cleave more than 10,000 ACh molecules per second13. AChE is substrate specific in nature and is found in high concentrations in the brain, while BChE is nonspecific and is distributed throughout the body14. In particular, it is associated with glial and endothelial cells in the brain15. In AD, the AChE level in the brain decreases progressively, but BChE level remains the same or increases up to 165% of the normal level16. This altered enzymes levels contribute to their different activity as the severity of AD advances17. ratio of BChE: AChE shifting from 0.6 to as high as 1.1 contributes to the formation of cholinergic deficits in these regions, leading to the behavioural, and cognitive dysfunction18–21.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            },
            {
                "n_rp": 13,
                "xref_id": "CIT0013",
                "rp_string": "13",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),348,176)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Cholinesterase is the enzyme which catalyses the hydrolysis of ACh and thus inhibition of cholinesterase can be an effective way for the treatment of AD10. It is well-known that two different cholinesterase (ChE) enzymes, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE), are responsible for the hydrolysis of ACh within the brain11. However, AChE has stronger acetylcholine hydrolytic activity than BChE does under the same condition12, as former enzyme can cleave more than 10,000 ACh molecules per second13. AChE is substrate specific in nature and is found in high concentrations in the brain, while BChE is nonspecific and is distributed throughout the body14. In particular, it is associated with glial and endothelial cells in the brain15. In AD, the AChE level in the brain decreases progressively, but BChE level remains the same or increases up to 165% of the normal level16. This altered enzymes levels contribute to their different activity as the severity of AD advances17. ratio of BChE: AChE shifting from 0.6 to as high as 1.1 contributes to the formation of cholinergic deficits in these regions, leading to the behavioural, and cognitive dysfunction18–21.",
                "pl_xpath": "/article/body/sec[1]/p[3]"
            }
        ],
        [
            {
                "n_rp": 14,
                "xref_id": "CIT0014",
                "rp_string": "14",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),525,154)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 15,
                "xref_id": "CIT0015",
                "rp_string": "15",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),680,80)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 16,
                "xref_id": "CIT0016",
                "rp_string": "16",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[7]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),761,138)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 17,
                "xref_id": "CIT0017",
                "rp_string": "17",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[8]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),900,100)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0018",
                "rp_string": "18–21",
                "pl_string": "18–21",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1001,186)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 19,
                "xref_id": "CIT0019",
                "pl_string": "18–21",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1001,186)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 20,
                "xref_id": "CIT0020",
                "pl_string": "18–21",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1001,186)",
                "containers_title": [
                    "Introduction"
                ]
            },
            {
                "n_rp": 21,
                "xref_id": "CIT0021",
                "pl_string": "18–21",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1001,186)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 22,
                "xref_id": "CIT0018",
                "rp_string": "18–21",
                "pl_string": "18–21",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "pl_xpath": "/article/body/sec[1]/p[3]/xref[9]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1001,186)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 23,
                "xref_id": "CIT0022",
                "rp_string": "22",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),1,100)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 24,
                "xref_id": "CIT0023",
                "rp_string": "23",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),102,180)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 25,
                "xref_id": "CIT0024",
                "rp_string": "24",
                "rp_xpath": "/article/body/sec[1]/p[4]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[4]),362,100)",
                "containers_title": [
                    "Introduction"
                ]
            }
        ],
        [
            {
                "n_rp": 26,
                "xref_id": "CIT0025",
                "rp_string": "25",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,232)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Current Food and Drug Administration (FDA) approved cholinesterase inhibitors namely: donepezil25, rivastigmine,26 and galantamine27, help only in postponing the onset of the symptoms of AD and do not treat the underlying disease28.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 27,
                "xref_id": "CIT0026",
                "rp_string": "26",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,232)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Current Food and Drug Administration (FDA) approved cholinesterase inhibitors namely: donepezil25, rivastigmine,26 and galantamine27, help only in postponing the onset of the symptoms of AD and do not treat the underlying disease28.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 28,
                "xref_id": "CIT0027",
                "rp_string": "27",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,232)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Current Food and Drug Administration (FDA) approved cholinesterase inhibitors namely: donepezil25, rivastigmine,26 and galantamine27, help only in postponing the onset of the symptoms of AD and do not treat the underlying disease28.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            },
            {
                "n_rp": 29,
                "xref_id": "CIT0028",
                "rp_string": "28",
                "rp_xpath": "/article/body/sec[1]/p[5]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[5]),1,232)",
                "containers_title": [
                    "Introduction"
                ],
                "pl_string": "Current Food and Drug Administration (FDA) approved cholinesterase inhibitors namely: donepezil25, rivastigmine,26 and galantamine27, help only in postponing the onset of the symptoms of AD and do not treat the underlying disease28.",
                "pl_xpath": "/article/body/sec[1]/p[5]"
            }
        ],
        [
            {
                "n_rp": 30,
                "xref_id": "CIT0029",
                "rp_string": "29",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[1]/p[1]),1,119)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Protein and ligand library preparation"
                ]
            }
        ],
        [
            {
                "n_rp": 31,
                "xref_id": "CIT0030",
                "rp_string": "30",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[1]/p[1]),121,197)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Protein and ligand library preparation"
                ]
            }
        ],
        [
            {
                "n_rp": 32,
                "xref_id": "CIT0032",
                "rp_string": "32",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[1]/p[1]),319,201)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Protein and ligand library preparation"
                ]
            }
        ],
        [
            {
                "n_rp": 33,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[1]/p[2]),97,139)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Protein and ligand library preparation"
                ]
            }
        ],
        [
            {
                "n_rp": 34,
                "xref_id": "CIT0034",
                "rp_string": "34",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[1]/p[2]),237,102)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Protein and ligand library preparation"
                ]
            }
        ],
        [
            {
                "n_rp": 35,
                "xref_id": "CIT0033",
                "rp_string": "33",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[2]/p/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[2]/p),1,174)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Virtual screening"
                ]
            }
        ],
        [
            {
                "n_rp": 36,
                "xref_id": "CIT0036",
                "rp_string": "36",
                "rp_xpath": "/article/body/sec[2]/sec[1]/sec[2]/p/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[1]/sec[2]/p),488,131)",
                "containers_title": [
                    "Methods",
                    "Molecular modeling",
                    "Virtual screening"
                ]
            }
        ],
        [
            {
                "n_rp": 37,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[2]/sec[2]/sec/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[2]/sec/p),290,132)",
                "containers_title": [
                    "Methods",
                    "Biological assessment",
                    "Quantification of BChE inhibitory activity in a spectrophotometric assay"
                ]
            }
        ],
        [
            {
                "n_rp": 38,
                "xref_id": "CIT0004",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[2]/sec[3]/sec[2]/p/xref",
                "context_xpath": "substring(string(/article/body/sec[2]/sec[3]/sec[2]/p),1,444)",
                "containers_title": [
                    "Methods",
                    "NMR analysis of the top four hits",
                    "Compound 5"
                ]
            }
        ],
        [
            {
                "n_rp": 39,
                "xref_id": "CIT0038",
                "rp_string": "38",
                "rp_xpath": "/article/body/sec[3]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/p[1]),1,147)",
                "containers_title": [
                    "Results and discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 40,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/p[1]),149,262)",
                "containers_title": [
                    "Results and discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 41,
                "xref_id": "CIT0039",
                "rp_string": "39",
                "rp_xpath": "/article/body/sec[3]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[3]/p[1]),573,75)",
                "containers_title": [
                    "Results and discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 42,
                "xref_id": "CIT0040",
                "rp_string": "40",
                "rp_xpath": "/article/body/sec[3]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/p[2]),1,225)",
                "containers_title": [
                    "Results and discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 43,
                "xref_id": "CIT0041",
                "rp_string": "41",
                "rp_xpath": "/article/body/sec[3]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[3]/p[2]),620,276)",
                "containers_title": [
                    "Results and discussion"
                ]
            }
        ],
        [
            {
                "n_rp": 44,
                "xref_id": "CIT0037",
                "rp_string": "37",
                "rp_xpath": "/article/body/sec[3]/p[5]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[3]/p[5]),1,161)",
                "containers_title": [
                    "Results and discussion"
                ]
            }
        ]
    ]
}